Related Experiment Video
Updated: Apr 6, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
The Effect of an Autoimmune Protocol (AIP) Diet in Adults With Rheumatoid Arthritis: A Single Arm Crossover Pilot
Julianne J McNeill1, Gael J Mearns2, Rebecca Grainger3
1School of Sport & Recreation, Human Potential Centre, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
Background:
Individuals with rheumatoid arthritis (RA) often ask whether dietary changes or food exclusions can reduce symptoms. The Autoimmune Protocol (AIP) diet, an elimination-based approach, is popular on social media, with anecdotal reports of benefit, but lacks clinical evaluation in RA.
Objectives:
To assess the feasibility and effectiveness of an AIP diet on patient-reported outcomes (PROs) in adults with RA.
Methods:
In this single-arm, open-label pilot study, nine adults with RA followed their usual diet for 4 weeks and then an 8-week AIP diet in a free-living context. Weekly PRO measures included the Routine Assessment of Patient Index Data 3 (RAPID3) and RA Impact of Disease (RAID) as primary outcomes. Secondary outcomes included 3-day weighed food records and biometric measurements (weight and waist circumference) collected at baseline and every 4 weeks. Adherence and ease of implementation were recorded weekly.
Results:
Nine participants (7 females, 2 males, aged 40-63 years) completed the intervention. From baseline to end week 12, mean RAPID3 scores decreased from 2.73/10 (range 0.2-5.37) to 0.99 (0-2.5). Four participants demonstrated a clinically meaningful reduction and three others reached remission from low disease activity. Mean RAID scores decreased from 3.13/10 (0.1-6.35) to 1.02 (0-2.96). Fatigue, sleep and pain improved. Mean body mass index reduced from 26.3 kg/m2 to 24.5 kg/m2. The diet was feasible with high adherence.
Conclusions:
An 8-week AIP diet was associated with improvements in PROs in seven of nine participants. These pilot findings support further controlled trials to confirm efficacy and explore mechanisms as a potential adjunct therapy for RA.
Trial Registration:
Number ACTRN12624001391561. https://www.anzctr.org.au/ACTRN12624001391561.aspx.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

